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Abstract
Hartsell, Zane McKinley. M.S. The University of Memphis. August 2012.
Efficacy of Three Antibiotic Loaded Biodegradable Polymer Coatings for Bone Screws.
Major Professor: Warren O. Haggard, Ph.D.
Biodegradable polymers have a potential for use in medical applications due to
their tailorable mechanical properties and their biocompatibility. Polymers have been
used in applications ranging from sutures to dialysis filters and even for intraocular
lenses. The purpose of this research was to evaluate the potential use of the following
biodegradable polymers: chitosan, poly l-lactic acid, and polyurethane, for potential use
as a local antibiotic carrier through their use as coatings for orthopaedic fixation screws.
Testing of the coatings included mechanical testing of the adhesion strength as well as
biological testing using zone of inhibition, activity, and elution testing. The results of
this study demonstrated that polyurethane maintained on average the most amount of
coating after insertion (98.2%) while all coatings produced a similar zone of inhibition.
The elution from the chitosan coating at the 1 hour time point was the only elution that
inhibited growth of Staphylococcus aureus.
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Preface
This thesis is presented with the understanding that the journal article submission
is presented as the main body of work. It is in that knowledge that the article titled,
“Efficacy of Three Biodegradable Polymer Coatings Loaded with Tobramycin for Bone
Screws,” has been submitted to the Journal of Orthopaedic Trauma. Therefore the article
submitted for publication serves as the body of work within this thesis manuscript.
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Chapter 1
1.1

INTRODUCTION

Problem Statement
The ever-rising cost of health care and increasing rate of infection combined with

increasing expectations from patients is driving healthcare providers and physicians to
reduce patient infections as well as the hospital stays and the procedures associated with
them. The Center for Disease Control reported in 2009 that there were greater than
500,000 surgical site infections per year1. This represents a large strain on the financial
well-being of the health care system and a large patient risk. It has also been reported
that the average cost of the treatment and subsequent surgeries for the revision to an
arthrodesis (fusion of the joint) due to infection and or other contributing factors is
$100,0002,3. With the risk of infection to the patient and increasing costs is there a way
for orthopaedic surgeons to incorporate a localized antibiotic into fracture fixation
without adding any time or difficulty to surgery? The use of a screw with local drug
delivery capabilities has been long-discussed as a potential mechanism to mitigate the
detrimental effects of bacteria in the fracture fixation of open fractures and wounds with
high infection risk4. One method of local delivery of antibiotics is through a screw with a
degradable coating. The question of the type of coating best suited for the application
still remains unanswered.
1.2

Hypothesis
The purpose of the study is to compare the effectiveness for local delivery of three

different types of coatings for orthopaedic trauma implants. The biomaterials to be tested
are polylactic acid, chitosan, and polyurethane all loaded with a common antibiotic,
tobramycin. The hypothesis of this study is that these degradable biomaterial coatings
will be effective carriers and local delivery systems for antibiotics under biological,
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physical, and mechanical tests. Effectiveness will be defined as retention of 80% of
coating during insertion, active eluted antibiotics, and antibiotic elution profile for
infection prevention.
1.3

Literature Review

1.3.1

Introduction
In light of the aforementioned clinical predicament of the increasing incidence of

surgical site infections and the reported increase of 0.2% per year in orthopaedics3, three
biomaterial coatings were selected to be researched and evaluated. The primary criterion
for the coatings was that they had to be degradable within the body4. Additionally, the
selection process encompassed one biomaterial that is currently used commercially for
local antibiotic delivery5, one biomaterial that is being evaluated for clinical use as a local
antibiotic carier6, and one novel biomaterial. Therefore, polylactic acid, chitosan, and
polyurethane were selected, respectively.
1.3.2

Chitosan
Chitosan is a linear polysaccharide composed of N-acetyl glucosamine and D-

glucosamine, as shown by the molecular diagram in Figure 16-8. Chitosan is a naturally
occurring polymer produced by the deacetylation of chitin, which is found in the
exoskeleton of crustaceans.

The degree to which the chitin is deacetylated is known as

the degree of deacetylation or DDA. The DDA can be altered to tailor the degradation
profile as well as the mechanical properties of the product produced from the chitosan6.
Chitosan has been used in many applications, including coatings for medical implants,
drug delivery, and bandages. Its biocompatibility and biodegradable properties makes it
an attractive selection for medical applications.
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Figure 1. Molecular structure of Chitosan9

The degradation of chitosan in vivo is carried out by enzymatic degradation.
Lysozymes in the body hydrolyze the glucosamine linkages, yielding saccharides and
glucosamines. These byproducts are found in the extracellular matrix of chitosan and
therefore provide minimal biologic response following degradation10.
Researchers in the past have used chitosan in various forms for medical
applications. Green et al. used chitosan for a coating of a bone screw to be used in
contaminated fractures6. Norowski et al. used chitosan as a coating on titanium implant
to elute antimicrobials. Sivakumar et al. incorporated gentamicin into a chitosan and
hydroxyapatite composite microsphere to characterize the release kinetics. He showed
that 80% of the antibiotic had been released at the 84 hour time point7. Chitosan has also
been explored as a replacement for polymethylmethacrylate beads for deep infections8.
1.3.3

PLA
The use of poly lactic acid (PLA) has been well-defined in the past studies as a

local delivery but less as a coating on a fracture fixation device11-13. The polymer has
been formed into plates and screws for small bone fixation, such as hand and foot
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applications11. Additionally, PLA has been utilized for sutures and patches for soft tissue
injuries12,13.
Poly lactic acid is a polymer that is produced from bacterial synthesis of
carbohydrates, such as corn and potatoes13. PLA is unique in that the molecular weight
and thus the degradation rate can be altered by altering the ratio of its two isomers (L,
D)12,13. The addition of the d-isomer reduces the glass transition temperature as well as
the molecular weight of the polymer. The ability of PLA to be tailored has made it an
attractive choice for medical devices such as tissue patches, sutures and bone screws and
plates13. A figure showing a typical configuration of PLA is found in Figure 2.

Figure 2. Representative molecular structure of Polylactic Acid14

The typical degradation of the PLA in vivo is through the process of hydrolysis.
The degradation products produced are lactic acid molecules that are naturally occurring
in the body and can be broken down by the tricarboxylic acid cycle15. Since the body is
accustomed to processing PLA’s byproducts, PLA is non-toxic unless the buildup of
lactic acid that occurs. This buildup has been shown clinically to result in inflammation
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following the intraosseous implantation of PLA16. Additionally, a mild inflammatory
response was reported by Paivarinta et al.17 and could lead to bone loss.
1.3.4

Polyurethane
Polyurethane was selected as a potential biomaterial coating because of its prior

applications in its non-degradable form, including hemodializers, catheters and wound
dressings18,19. Polyurethane has been used extensively in the medical field as a
biological-containing substance due to its hemocompatibility and biocompatibility18.
Polyurethanes are molecular structures that are composed of a hard and soft
segment that can be selected based on the desired mechanical properties. Polymerization
of urethanes is typically done with a catalyst via a condensation reaction. The structure
of polyurethane can either consist of benzene rings (aromatic) or hydrocarbon backbones
(aliphatic diisocyanates)18,19. The aromatic structure tends to be more chemically stable
and have more chain strength. The aliphatic structure is less chemically stable and thus is
able to be biodegradable18. Degradation of the aliphatic urethane is carried out though
hydrolysis, yielding the byproducts of lactic acid and other non-acidic molecules19. A
basic molecular structure for polyurethane can be found in Figure 3.

Figure 3. Molecular structure of polyurethane19
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1.3.5

Other Coatings
There are many other biomaterials that have been used for biomedical

applications, both degradable and non-degradable. Other biomaterials such as bioglass,
polycaprolactone, polyester, polymethylmethacrylate (PMMA), and polyglycolic acid
(PGA) have been used for coatings and drug delivery16,19-21. Polymers have been
investigated for applications ranging from PMMA arthrodesis fixation which is nondegradable to PGA sutures which are degradable. Polymers vary considerably in their
mechanical properties, in that they can accommodate both high compressive forces,
making them appropriate options for load-bearing applications4,13,15, as well as high
tensile forces, making them useful for soft tissue sutures4,15. This versatility makes them
attractive as candidates for most applications associated with orthopaedics including
antibiotic eluting devices and coatings, where tailorable implants are desirable.
In the past, the uses of polymers in antibiotic release or infection prevention have
been focused on either the addition of antibiotics to PMMA bone cement that can be
added to joint replacements after revisions due to infection, spacers, or PMMA beads that
are added to segmented fractures of long bones22. One disadvantage of PMMA beads for
use in trauma applications is the requirement of an additional surgery to remove the nondegradable beads22-23.
1.3.6

Tobramycin
Tobramycin is an aminoglycoside commonly used by orthopaedic surgeons for

both the treatment of bone infections23 and for infection prophylaxis in open tibial
fractures24. The main mechanism of action of tobramycin is inhibition of bacterial
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protein synthesis24. Tobramycin is active against some Gram-positive bacteria, including
Staphylococcus aureus and Staphylococcus epidermidis, and Gram-negative bacteria.
Tobramycin was discovered in the 1970’s to be effective in treating Pseudomonas
aeruginosa and then was adopted as a treatment for cystic fibrosis in the 1990’s24.
Presently it is used to treat selected severe Gram-positive and most Gram-negative
infections that are resistant to other more commonly used antibiotics. One significant
adverse effect associated with using tobramycin is the potential effect on the liver. Other
complications associated with the use of tobramycin are neurotoxicity, ototoxicity, and
nephrotoxicity23-24. Adverse side effects typically occur when doses are above the
therapeutic range. The mechanism of action of intravenous and intramuscular injections
necessitates the repeated treatment with antibiotics and checking for toxic serum levels2324

. The complications associated with systemic deliver of antibiotics and ability for high

localized concentrations of antibiotics could be obtained by localized delivery with a
coating23-24.
1.3.7

Summary
The occurrence of infection associated with extremity trauma treatments is an

ongoing health problem that can be mitigated, but enhanced treatment methods must be
pursued. The scope of the benefit of preventing infection goes beyond the well-being of
the patient and effects many other aspects of healthcare. For example, the cost of a
surgery to repair a fractured hip with a trauma product ranges from approximately
$14,000 to $24,000 dollars, according to Edwards et al25. Further, the authors cite an
increase in cost of approximately 100% when the patient becomes infected postsurgery25. In addition to the increased cost associated with infection, the prolonged
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hospital stay could cause overcrowding, thus reducing staff available to care for new
patients. These effects are further compounded when the possibility of revision surgery
for some patients is considered.
In recent research, there has been a large emphasis on biocompatible and
biodegradable polymers for medical use. The use of a completely biodegradable implant
for load-bearing fracture fixation has had some setbacks due to issues surrounding their
mechanical properties and the reaction of the surrounding tissue to the degradation
products16-17. However, the use of a biocompatible and biodegradable polymer that can
be tailored for certain applications, such as local delivery of drugs and or cells, have
shown much promise. Potential applications for this technology can be found anywhere
from stents and heart valves to bone void fillers and implant coatings4. The proposed
research will show the efficacy of three different polymer coatings added to bone screws,
furthermore these preliminary results will also provide information that could be
generalized to additional applications where the polymer is incorporated into various
orthopaedic devices.
One major drawback of the most common local antibiotic carriers is that they are
not biodegradable. This drawback can be represented by antibiotic-impregnated PMMA
beads. PMMA beads are widely used in severe comminuted fractures with great success;
however, PMMA is non-degradable and prevents surrounding bone from remodeling
completely22-23. While the beads are effective at reducing or potentially eliminating
infection, the requirement of removal via a second invasive surgery makes them a less
than ideal final solution to the problem of orthopaedic infection22-23. The opportunity for
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a novel biodegradable carrier to transform this clinical therapy is may be possible with
utilization of the biomaterials evaluated in this research project.
The biodegradable polymers that will be tested are chitosan, PLA, and degradable
polyurethane that have been impregnated with tobramycin. The coated screws will be
subjected to mechanical tests to assess the adhesive strength of the coatings.
Additionally, coated screws will undergo biological testing to assess their efficacy. The
biological tests will include the effect of screw coatings on growth of bacteria as
indicated by a zone of inhibition and by the ability of the eluates of the coated screws to
inhibit growth of bacteria. These evaluations will provide partial validation of the
coatings and will give a platform to rank the effectiveness of the materials.
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Chapter 2

JOURNAL ARTICLE SUBMISSION

Efficacy of Three Biodegradable Polymer
Coatings Loaded with Tobramycin for Bone
Screws
Zane Hartsell1,2 BS, Joel Bumgardner PhD2 Harry Courtney PhD3, Mark Gosney
MS1, Warren Haggard PhD2
1
Smith & Nephew Orthpaedics, Inc 2 University of Memphis
3
University of Tennessee Health Science Center

Objective: Infection is at an elevated risk in grade three-type long bone fractures. The
current method for prophylaxis in a compromised fracture is the administration of
antibiotics intramuscularly or intravenously. Both of these administration routes yield
less than effective antibiotic dosage at the fracture site and in the surrounding tissue.
Ineffective antibiotic dosage also results from the poor vascular support at the fracture
site. With controlled release of antibiotics by a coating on the orthopaedic fracture
fixation device, an effective antibiotic dosage could be achieved and maintained locally,
near the contaminated bone fracture.
Methods: Sterilized screws (n=15) were coated with chitosan, poly l-lactic acid (PLLA),
or degradable polyurethane that has been impregnated with 5 wt% tobramycin. Screws
(n=5 for each coating type) were then assayed for tobramycin elution profiles, for effect
of eluates on staphylococcal growth, for zones of inhibition of bacterial growth on agar
plates, and for effect of screw insertion on coatings
Results: Each of the three coating types produced a zone of inhibition of bacterial
growth of approximately 26 mm in diameter. The elution study showed that the chitosan
coating had the largest burst release (1 hour time point) while the PLLA showed a release
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over 48 hours and the polyurethane produced a consistent elution (79ug/day) over the 168
hour study. The polyurethane coating maintained 98.2% adherence after insertion which
was the highest. Elute from the chitosan coating (1 hour time point) was the only one that
was able to reduce the S. aureus colony in solution.
Key words: Chitosan, Polylactic Acid, Polyurethane, Coating, Antibiotic
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Introduction
Infection in some extremity trauma is an ongoing clinical problem that requires
mitigation with current practices to help reduce its rate and the associated health care
expenses. The scope of the benefit of preventing infection goes beyond the well-being of
the patient and effects many other aspects of healthcare. For example, the cost of a
surgery to repair a fractured hip via internal plating or intramedullary nailing is between
$14,000 and $24,000 dollars, according to Edwards et al1. In contrast, it has been
reported that the average cost of the first revision due to infection is on the order of
$100,0002,3. In addition to the increased cost associated with infection there are also
concerns with prolonged hospital stay and increased risks of nosocomial infection. These
effects are further compounded with the immunocompromised patients of revision
surgery3.
Over the last 10 years, a large investment has been made into the research of
biocompatible and biodegradable polymers for medical use especially in local drug
delivery and tissue engineering4,5. The use of a completely biodegradable implant for
load-bearing fracture fixation with or without antibiotics has had some setbacks due to
issues surrounding their mechanical properties and the reaction of the surrounding tissue
to the degradation products6. The use of a biocompatible and biodegradable polymers
coupled with metallic components has showed much promise. Potential applications for
this technology can be found anywhere from stents and heart valves to implant coatings7.
This polymer investigation evaluates the efficacy of three different biomaterial polymer
coatings on bone screws for fracture fixation for local delivery of antibiotics in extremity
trauma.
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A major drawback of the most common local antibiotic carriers is their lack of
biodegradation. This absence of biodegradation can found in antibiotic impregnated
PMMA beads and spacers8,9. The use of PMMA beads is widely used in severe
comminuted fractures and with great success; however, PMMA is non-degradable and
prevents the surrounding bone from remodeling completely10. While the beads are
effective at reducing or potentially eliminating infection, the requirement for removal
through a second procedure makes them a less than ideal final solution to the problem of
infection8-10. The opportunity for a novel biodegradable carrier to transform clinical
therapy is possible with utilization of the biomaterial polymers evaluated in this research
project.
The purpose of this study was to evaluate three different degradable polymers for
their potential for use in a contaminated fracture. The polymers that were tested were
chitosan, poly l-lactic acid (PLLA), and degradable polyurethane that were impregnated
with tobramycin. Bone screws with these coatings were subjected to mechanical tests to
assess the adhesion strength of the coating as well as the effect of fatigue on the coating
strength. Additionally, coated screws underwent biological testing to assess their
efficacy. The biological tests included zone of inhibition, activity testing against
Staphylococcus aureus and elution testing. The results of in-vitro testing highlight the
relative performance of the different coatings. Effectiveness will be defined as retention
of 80% of coating during insertion, active eluted antibiotics, and antibiotic elution profile
for infection prevention.
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Methods and Materials
Sample Preparation
Samples for all portions of this study were prepared in the same manner. Prior to
coating, the 4.5mm cortical bone screws (Smith & Nephew, Inc) were cleaned and
ultrasonicated in methanol and autoclaved using a pre vacuum cycle at 54.4°C for 4
minutes (SV-116, Steris Co., Mentor, OH). All samples received their respective coating
impregnated with 5 wt% Tobramycin (Fisher Scientific, Pittsburg, PA) with the
following methods.
The screws for this study were all coated by a dip coating process. To produce
the chitosan coating, 2.0g of 80% DDA chitosan (Vanson Halosource, Bothel, Wa) was
combined with 30mL of deionized water in a 50mL vial. 1.5mL of Lactic and 0.5mL of
acetic acid were then added to the vial and mixed until the solution was homogeneous.
Tobramycin was then added at 5wt% and then the solution was placed on a vortex mixer
(Mini Vortexer, VWR, Radnor, PA) until well mixed. The screws were then manually
dipped once into the solution for approximately one second.
The PLLA coating was produced by mixing 2.65g of PLLA (PURASORB 38
Purac, Gorinchem, Netherlands) and 50mL of chloroform. The solution was placed in an
oil bath at 50°C with a stir bar to facilitate dissolving the PLLA. Tobramycin was then
added to the solution at 5 wt% and mixing continued till homogenous. The screws were
then manually dipped once into the solution for approximately one second.
A polyurethane coating was produced by mixing 10g of pre-polymer A
(isocynate) and pre-polymer B (aliphatic) at a 70/30 ratio (PolyNovo, Port Melbourne,
Australia). The pre-polymer mixture then added to a premixed solution (5mg of
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dibutyltin dilaurate (Sn catalyst), 6.67g of chloroform (CHCl3), and 5 wt% tobramycin)
and was mixed until homogeneous. The screws were then manually dipped once into the
solution for approximately one second.
All screws were dipped ½ of the way up the shaft of the screw (Figure 1a). To
facilitate drying and to help ensure even coatings, all screws were fixed on a custom
rotating fixture (30 RPM) such that they were perpendicular to the ground (Figure 1b).

A

B
Figure 1. Coated screws (A), Custom drying fixture (B)

Zone of Inhibition Testing
To test the ability of the coated screws to inhibit growth of S. aureus, a zone of
inhibition test was performed. S. aureus Cowan I strain was grown overnight at 37°C in
Tryptic soy broth (TSB) and a 100 µl aliquot of 1:10 dilution of the overnight growth of
S. aureus was plated on TSB agar plates. Bone screws coated with each coating material
(n=3) and loaded with 5% tobramycin were then added to the agar plates and pressed
down to ensure maximum contact with the substrate. Plates were then incubated for 24
hours at 37°C before measuring the zone of inhibition of growth as indicated by a clear
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zone surrounding the screw. The diameters of the zones of inhibition were measured
perpendicular to the shaft of the screw.
Elution Testing
The capability of the coatings to have a sustainable release and desirable
antibiotic elution profile was assessed over a 7 day period. Screws coated with each
coating type (n=5) were weighed prior to commencement of testing. 2mL of phosphate
buffered solution (PBS) was added to the 5mL vials containing the screws and they were
placed in an oscillating incubator set at 37°C oscillating at 50 rpm (Barnstead Max Q
400, Thermo Scientific, Waltham, MA). Due to the small volume of the test media the
solubility of tobramycin was checked to be 538mg/mL, therefore the ability to suspend
all the eluted tobramycin was not problematic. The PBS solution was removed and
stored for analysis and replaced with fresh PBS at the following time points: 1, 2, 4, 8,
12, 24, 48, 72, 96, and 168 hours. Upon collection of the PBS solution, samples were
frozen (-20°C) until analysis. Analysis of the solution was done by a TDxFLx instrument
(Abbott Laboratories, Abbott Park, IL). Calibration was done prior to testing with a 0.5,
4, and 8 µL/mL concentration calibration kit. For specimen analysis, 80µL of the
collected samples was added to the sample tray. Some samples were retested at higher
dilutions due to them being out of the calibration range of the instrument.
Testing for Antimicrobial Activity
Antimicrobial activity testing was performed to evaluate the efficacy of the
tobramycin in the eluates to inhibit bacterial growth. S. aureus Cowan I strain was grown
overnight at 37°C in TSB and diluted 1:5 with TSB. Tubes were prepared containing the
following: 1.75 ml of TSB, 200 µl from each eluate, and an inoculum of 50 µl of the 1:5
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dilutions of S. aureus.

Positive controls consisted of tubes in which 200 µl of the eluate

was replaced with 200 µl of PBS. Negative controls consisted of tubes in which 50 µl of
TSB was used instead of 50 µl of S. aureus. All samples of eluate were diluted 1:10 for
antimicrobial assays according to previous testing protocols12. The tubes were incubated
at 37°C for 18 hours and then the absorbance at a 530nm (A530) was measured on a
spectrophotometer (Spectronic 20 Genesys: model 4001, Thermo Scientific).
Insertion Testing
Insertion testing was performed to evaluate the adherence of the coating as well as
to determine if the addition of the coating altered the needed torque for insertion.
Prepared 1 inch thick blocks of 20 pcf foam (General Plastic, Last-a-foam 3720) received
a 3.5mm predrill per the manufacturer’s surgical technique11. The blocks were then
attached to a custom screw testing machine (Figure 2). The coated screws (n=5) of each
material were then inserted at a rate of 5RPM with a 22.24N force in line with the long
axis of the screw to ensure engagement in the foam. The screws were inserted for 10
revolutions. LabView (v8.0, National Instruments, Austin, TX) was used to record the
maximum torque produced during insertion, and the screws were weighed after testing to
quantify the amount of lost coating.
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Figure 2. Screw insertion test setup

Statistical Analysis
The results of the individual experiments were evaluated using statistical
comparisons done with ANOVA single-factor using Tukey method with significance
declared at 95% confidence (Minitab 16, State College, PA).
Results
Zone of Inhibition Testing
The zone of inhibition test was used to determine if the antibiotic remained active
after the use the solvents used in coating process or any other aspect of the coating
procedures. It was shown there was an initial kill zone for all coating types and they
were of similar size. Each of the coating types produced a zone of inhibition of bacterial
growth of approximately 26 mm in diameter (range 25-29 mm), and there was no
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statistically significant difference between the coatings. This result was consistent with
Greene et al.12 who coated stainless steel with gentamicin impregnated chitosan and saw
a similar zone of inhibition. Representative images from the uncoated and coated screws
can be seen in figure 3.

Figure 3: Representative zone of inhibition results: uncoated(left) and PLA coated(right)

Testing of the eluates for antimicrobial activity showed that there was only
inhibition of bacterial growth at the 1 hour time point for the chitosan samples. This was
due to the burst release of tobramycin. The other specimen’s aliquots were not able to
inhibit the growth of S. aureus. Since the solution was exchanged at each time point, the
additive effect of the previous time point’s elution could not be assessed.
Profile of Antibiotic Elution
The elution testing showed that the elution profiles of the three coatings were
dissimilar in amount released and time of release (Figure 4). The chitosan samples
showed a large burst release in the first hour of the elution testing. This burst release was
likely due to the disassociation of the coating from the screw in the testing environment
and therefore the subsequent time points did not yield any additional tobramycin elution
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for the chitosan samples. The PLLA screws also showed a burst release, albeit of a lower
magnitude, followed by a steadily tapering elution over the next 7 days. The
polyurethane coated screws showed the smallest burst release with the most consistent
release over time. The most effective release profile for bacterial inhibition to prevent
infection is not completely known. Many researchers have suggested a burst release
followed by a continued release above the minimum inhibitory concentration of the
contaminating bacteria13.

total amount (ug)

1000
800
600
400
200
0

A

0

20

40

60

80

100

120

140

160

180

0

20

40

60

80

100

120

140

160

180

0

20

40

60

80
100
Time (hours)

120

140

160

180

total amount (ug)

1000

total amount (ug)

B

800
600
400
200
0

4000
3000
2000
1000
0

C

Figure 4. Elution testing results of Chitosan(A), PLLA(B), and Polyurethane(C). Dashed
lines represent respective amount of loaded antibiotics
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Insertion Testing
Insertion testing was used to evaluate the potential increase in screw insertion
force with the different coatings as well as to quantify the amount of coating that was lost
due to insertion into a foam bone surrogate. The insertion torque generated for the coated
screws was 1.70±0.22, 2.02±0.24, and 2.91±0.54 in-lbf, for the chitosan, PLLA and
polyurethane, respectively (Figure 5). The insertion torque generated by all three
coatings showed a statistically significant increase (p>0.05) from the uncoated screw.
Additionally, the insertion torque of each coated screw was significantly different
(p<0.05) than the others, with the insertion torque of the polyurethane group being the
highest.

Insertion Torque (in-lbf)

Insertion Torque
5
4.5
4
3.5
3
2.5
2
1.5
1
0.5
0
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*
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Uncoated

Chitosan

PLLA

Figure 5. Results of insertion torque testing
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PU

The results of the coating lost during insertion weight measurement showed that
the chitosan-coated screws exhibited the highest amount of coating lost, followed by the
PLLA and the polyurethane, respectively (Figure 6). The percentage of coating lost was
21.18±18.03%, 3.3±2.53%, and 1.78±0.89% for the chitosan, PLLA and polyurethane,
respectively. These results indicate that under insertion, the polyurethane coating
produces the most resistance to delamination from the substrate.

Coating Lost (%)

Coating Lost During Insertion
50
45
40
35
30
25
20
15
10
5
0

*
*

Chitosan

PLLA

PU

Figure 6. Results of coating lost during insertion testing
Discussion
In a review article by Hofmann et al. the use of biodegradable polymer coatings to
elute antibiotics has been described by many researchers in the past has shown great
advancement14. To evaluate these coatings researches have performed tests that assess
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the mechanical, biological, as well as efficacy of the coatings to prevent bacteria
proliferation. It was the aim of this study to directly compare three such coatings under
identical conditions to be able to quantify their advantages and disadvantages.
Interestingly, these results showed delamination of chitosan and release of the
majority of the antibiotic in the first hour of the elution study. The delamination is not
consistent with Greene et al.12 that showed coating attachment over a 96 hour elution
study. One potential reason for this difference is the coating method used by Greene
involved a silane treatment which has been shown to increase surface adherence.
However, the elution of the majority of the antibiotics was consistent with Greene et al.12
and Aimin et al.15 which both showed a nearly 10 fold decrease in elution amount from
the first to the second time point of their respective elution studies using antibiotic loaded
chitosan. The PLA curve was also consistent with literature. Mader et al.16 showed in a
longer elution study of tobramycin from PLA a peak release rate at day 2 and then a drop
off for the remainder of the time points out to 42 days.
The use of other polymers such as polycaprolactone and polylactic acid\glycolic
acid in other studies have shown efficacy in situations where bacteria was present16,17.
The benefit in this study, as well as studies by Mader et al.16 and Chang et al.18, is that
they show the elution and beginning of degradation of biodegradable polymers. This
research as well as other studies12-15 show the potential for and need for a biodegradable
polymer that can locally release antibiotics and not have to be removed prior to
consolidation of the bone.
Biodegradable polymer coating of orthopaedic implants is one of the potential
methods of infection prevention in open fractures. The ability to add antibiotics to
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biodegradable polymers and to manipulate their degradation profiles offers an attractive
option for infection prevention and control. The localization and controlled release from
coated fracture fixation devices of the antibiotics could enhance the control of infections
in complex or compromised trauma injuries.
This polymer study illustrates the possible benefits and limitations for three
polymeric coatings. While all three coatings inhibited the growth of S. aureus on agar
plates, the chitosan coating was the only coating eluted a tobramycin concentration that
reduced the S. aureus colony in solution, and only at the earliest time point. The
polyurethane coating provided the most resistance to delamination during implantation
and potentially produces an attractive elution profile. Future studies with higher
antibiotic loading levels will be pursued to determine if the coatings can provide infection
prevention over a more extended period of time.
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Chapter 3

CONCLUSIONS

The research conducted for this thesis was to assess the potential for three
different degradable polymeric coatings to be applied to bone fracture fixation devices in
the hope of preventing infection and or colonization of bacteria in compromised or open
fractures. To evaluate the potential efficacy, three degradable antibiotic coatings were
applied to orthopaedic bone screws and testing under simulated physiological conditions.
The coatings used were PLLA, chitosan, and polyurethane. This included insertion
testing to evaluate coating adhesion strength, zone of inhibition testing to evaluate if the
antibiotic is still biologically active, elution testing to determine the release profiles, and
activity testing to evaluate eluted antibiotic efficacy over time.
The mechanical testing performed showed that the polyurethane produced the
coating most adhered to the screw surface. The adherence ranking was followed by the
PLLA and chitosan coatings. The zone of inhibition testing showed no difference
between the coatings with all of the coatings yielding a similar size and shaped clear
zones around the coated implant after 24 hours against S. aureus. This zone of inhibition
evaluation demonstrated that the coating techniques and solvents maintain some
antibiotic activity for the tobramycin.
When evaluating the release of the antibiotics from the degradable coatings, each
of the evaluated coatings did produce a unique elution curve. The chitosan coating
produced a burst release in the first hour with almost complete elution of all of the
antibiotics in the coating. The PLA and polyurethane coatings both had extended elution
periods that spanned the seven day test. The profile of the PLA was characterized by an
initial burst release over the first 24 hours and then a gradual decrease through the
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seventh day. The polyurethane coating profile showed a nearly linear elution curve after
the burst release in the first hour. Activity testing was completed on all aliquots collected
from the elution study and the only sample that yielded a concentration above the
minimum inhibitory concentration was the first hour’s release of the chitosan sample due
to the burst release. Therefore, the coatings selected for this research each showed
unique potentials for use in infection prevention in orthopaedics.
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Chapter 4

FUTURE WORK

The presented work will need to be followed up with much iteration for
formulations as well as experiments to test the preclinical efficacy prior to clinical
studies. Initially there will need to be a more extensive quantification of the coating
applied to the implant. Coating thicknesses were optimized on flat disks prior to
incorporation of the bone screw. Further optimization will need to be done on screws to
maintain consistent thicknesses between coating types. Additionally, the effect of coated
screws without the incorporation of antibiotics needs to be evaluated to measure the
ability of the virgin coating to inhibit bacterial growth or any potential solvent residue
leaching. This will allow a more accurate assessment of the benefit of the incorporated
antibiotics.
The current antibiotic loading level was only effective in inhibiting the growth of
Gram-positive bacteria but not reduction in bacterial presence over time. If the thin
coating of an implant it is to be effective in preventing biofilm and reduction of bacterial
presence in tissue future iterations will need to have a higher concentration of antibiotics.
Additionally, the use in trauma applications will necessitate the use of, at a minimum, six
screws for fixation. The additional screws would allow for the additive effect when
evaluating if the MIC level can be reached. The mechanism and potential for this
phenomenon will need to be assessed.
After creating an effective elution profile, another opportunity for future work for
this project will be the incorporation of an animal model. A small animal model would
be used to test the efficacy of the coating in preventing infection. A rabbit model would
be ideal due to its wide spread use in orthopaedic implant studies. A 1 cm segment of
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bone would be removed from the rabbit’s femur and then the bone would be fixed with a
small plate and fixed with coated screws. Fixation would likely be done with a plate
intended for the hand or fibula. Prior to closure the fracture site would be inoculated via
an injection of S. aureus inoculum. Additionally, the efficacy of the coating in the
elimination of a biofilm could be tested in an animal model. This animal model will lead
to a better understanding of the additive effect of the antibiotics and the clearance rate of
the antibiotics from the infected site.
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APPENDIX
This appendix will persent additional figures and data that was not put into the main body
of the thesis.

The above image was captured to show the addition of chitosan coating to the bone
screw. Image of coated (left) and un-coated screws (right).
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The elution study was completed in an oscillating incubater (seen above) with the screws
sitting vertically in the sealed vials. The PBS for media excange was also kept in the
same incubater to ensure that there was not a period of time where the media was
equilibrating to the incubater temperature.
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The above image showes the oil bath and associated glass ware used for desolving ,
mixing, and heating the PLLA prior to coating the screws. Water was continuoulsy
passed through the condensation tube.
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After coating photographs were taken of different samples from each coating group. The
image above represents the following: polyurethane (left), PLLA (center), and chitosan
(right). The dashed line shows where screws were coated approximately half way up the
threaded shaft.
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After elution testing analysis was done to compare the theoretical amount of tobramycin
loaded onto each screw based on coating thicknesses. All values were normalized based
on original screw weight and coated screw weight.
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The above image shows the complete zone of inhibition results from each of the coating
groups. The third sample of the chitosan group has different shape due to the screws
being dropped in the dish prior to seating it in its final position. This however did not
affect the results of the test.
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Coating type
uncoated -1
uncoated -2
uncoated -3
Avg
StDev
CH-1
CH-2
CH-3
Avg
StDev
PLLA-1
PLLA-2
PLLA-3
Avg
StDev
PU-1
PU-2
PU-3
Avg
StDev

Zone of
Inhibition (mm)
0
0
0
0.0
0.0
25
26
29
26.7
2.1
25
25
26
25.3
0.6
25
26
26
25.7
0.6

The tables above represent the raw data associated with the measurements taken after the
24 incubation period in the zone of inhibition testing.
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Coating thicknesses as measured by a JOEL SEM of the degradable polyurethane of
A)20 wt%, B) 27 wt%, C) 60 wt%, and D) 70 wt% polymer in chloroform solvent.
Coating thicknesses were optimized on flat coupons prior to being transferred to screws.
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Statistical comparisons were made using ANOVA single-factor; in order to make
multiple comparisons, the Tukey method was used post-hoc (α=0.05).

One-way ANOVA: insertion torque versus coating
Source
coating
Error
Total

DF
3
15
18

S = 0.3380

Level
Chitosan
PLLA
PU
uncoated

N
6
6
5
2

SS
4.958
1.713
6.671

MS
1.653
0.114

F
14.47

P
0.000

R-Sq = 74.32%

R-Sq(adj) = 69.18%

Mean
1.6993
2.0255
2.9056
1.5015

Individual 95% CIs For Mean Based on
Pooled StDev
---+---------+---------+---------+-----(----*----)
(----*----)
(----*-----)
(-------*--------)
---+---------+---------+---------+-----1.20
1.80
2.40
3.00

StDev
0.2244
0.2380
0.5423
0.0460

Pooled StDev = 0.3380

Tukey 95% Simultaneous Confidence Intervals
All Pairwise Comparisons among Levels of coating
Individual confidence level = 98.87%

coating = Chitosan subtracted from:
coating
PLLA
PU
uncoated

Lower
-0.2368
0.6158
-0.9940

Center
0.3262
1.2063
-0.1978

Upper
0.8891
1.7967
0.5983

--------+---------+---------+---------+(----*---)
(----*----)
(-----*------)
--------+---------+---------+---------+-1.2
0.0
1.2
2.4

coating = PLLA subtracted from:
coating
PU
uncoated

Lower
0.2897
-1.3201

Center
0.8801
-0.5240

Upper
1.4705
0.2721

--------+---------+---------+---------+(----*----)
(------*-----)
--------+---------+---------+---------+-1.2
0.0
1.2
2.4

coating = PU subtracted from:
coating
uncoated

Lower
-2.2199

Center
-1.4041

Upper
-0.5883

--------+---------+---------+---------+(-----*------)
--------+---------+---------+---------+-1.2
0.0
1.2
2.4
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One-way ANOVA: % coating lost versus coating
Source
coating
Error
Total

DF
2
14
16

S = 10.89

Level
Chitosan
PLLA
PU

SS
1345
1660
3005

MS
673
119

F
5.67

R-Sq = 44.76%

N
6
6
5

Mean
21.18
3.30
1.78

P
0.016

R-Sq(adj) = 36.87%

StDev
18.03
2.53
0.89

Individual 95% CIs For Mean Based on
Pooled StDev
---------+---------+---------+---------+
(--------*---------)
(--------*---------)
(----------*---------)
---------+---------+---------+---------+
0
10
20
30

Pooled StDev = 10.89

Tukey 95% Simultaneous Confidence Intervals
All Pairwise Comparisons among Levels of coating
Individual confidence level = 97.97%

coating = Chitosan subtracted from:
coating
PLLA
PU

Lower
-34.33
-36.65

Center
-17.88
-19.40

Upper
-1.43
-2.15

----+---------+---------+---------+----(----------*----------)
(----------*-----------)
----+---------+---------+---------+-----30
-15
0
15

coating = PLLA subtracted from:
coating
PU

Lower
-18.77

Center
-1.52

Upper
15.73

----+---------+---------+---------+----(-----------*----------)
----+---------+---------+---------+-----30
-15
0
15
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One-way ANOVA: zone of inhibition versus coating
Source
coating
Error
Total

DF
3
8
11

S = 1.118

Level
CH
PLLA
PU
uncoated

SS
1510.92
10.00
1520.92

MS
503.64
1.25

R-Sq = 99.34%

N
3
3
3
3

Mean
26.667
25.333
25.667
0.000

StDev
2.082
0.577
0.577
0.000

F
402.91

P
0.000

R-Sq(adj) = 99.10%

Individual 95% CIs For Mean Based on
Pooled StDev
--+---------+---------+---------+------(-*-)
(-*-)
(-*-)
(-*-)
--+---------+---------+---------+------0.0
8.0
16.0
24.0

Pooled StDev = 1.118

Tukey 95% Simultaneous Confidence Intervals
All Pairwise Comparisons among Levels of coating
Individual confidence level = 98.74%

coating = CH subtracted from:
coating
PLLA
PU
uncoated

Lower
-4.257
-3.924
-29.591

Center
-1.333
-1.000
-26.667

Upper
1.591
1.924
-23.743

+---------+---------+---------+--------(-*-)
(-*-)
(-*-)
+---------+---------+---------+---------30
-15
0
15

coating = PLLA subtracted from:
coating
PU
uncoated

Lower
-2.591
-28.257

Center
0.333
-25.333

Upper
3.257
-22.409

+---------+---------+---------+--------(-*-)
(-*-)
+---------+---------+---------+---------30
-15
0
15

coating = PU subtracted from:
coating
uncoated

Lower
-28.591

Center
-25.667

Upper
-22.743

+---------+---------+---------+--------(-*-)
+---------+---------+---------+---------30
-15
0
15
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Test for Equal Variances for zone of inhibition
Bartlett's Test
Test Statistic
P-Value

CH

3.70
0.157

Lev ene's Test
Test Statistic
P-Value

coating

PLLA

1.33
0.330

PU

uncoated

0
5
10
15
20
25
95% Bonferroni Confidence Intervals for StDevs

Test for Equal Variances for Percent coating lost
Bartlett's Test
Test Statistic
P-Value

Chitosan

27.03
0.000

Lev ene's Test

coating

Test Statistic
P-Value

PLLA

PU

0
10
20
30
40
50
60
95% Bonferroni Confidence Intervals for StDevs
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2.45
0.122

Test for Equal Variances for insertion torque
Bartlett's Test
Test Statistic
P-Value

Chitosan

6.64
0.084

Lev ene's Test
Test Statistic
P-Value

coating

PLLA

PU

uncoated

0
1
2
3
4
5
6
95% Bonferroni Confidence Intervals for StDevs

46

1.68
0.213

